Mitochondrial dysfunction and permeability transition in osteosarcoma cells showing the warburg effect

Journal of Biological Chemistry

Volumn 288, Issue 46, 2013, Pages 33303-33311

  Giang, An Hoa ^a   Raymond, Tamara ^a   Brookes, Paul ^a   De Mesy Bentley, Karen ^a   Schwarz, Edward ^a   O'Keefe, Regis ^a   Eliseev, Roman ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PERMEABILIZATION; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL FUNCTION; MITOCHONDRIAL PERMEABILITY TRANSITION; MITOCHONDRIAL SWELLING; OSTEOSARCOMA CELLS; PERMEABILITY TRANSITION; THERAPEUTIC TARGETS;

CELL CULTURE; DISEASES; METABOLISM;

MITOCHONDRIA;

CASPASE 3; CYTOCHROME C;

APOPTOSIS; ARTICLE; BIOENERGY; CELL MEMBRANE DEPOLARIZATION; CELL RESPIRATION; CELL STRUCTURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; FETUS; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; ONCOLOGICAL PARAMETERS; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WARBURG EFFECT;

CANCER; CYCLOPHILIN D; GLYCOLYSIS; MITOCHONDRIA; MITOCHONDRIAL PERMEABILITY TRANSITION; OSTEOSARCOMA; WARBURG EFFECT;

ANIMALS; CELL LINE, TUMOR; GLYCOLYSIS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; OSTEOSARCOMA; OXYGEN CONSUMPTION; PERMEABILITY;

EID: 84887828832     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.507129     Document Type: Article

References (48)

1. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314
2. Warburg, O. (1930) The Metabolism of Tumours, Constable Press, London
3. Gatenby, R. A., and Gillies, R. J. (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899
4. Wenner, C. E. (2012) Targeting mitochondria as a therapeutic target in cancer. J. Cell. Physiol. 227, 450-456
5. Ward, P. S., and Thompson, C. B. (2012) Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21, 297-308
6. Brandon, M., Baldi, P., and Wallace, D. C. (2006) Mitochondrial mutations in cancer. Oncogene 25, 4647-4662
7. Czarnecka, A. M., Czarnecki, J. S., Kukwa, W., Cappello, F., Scińska, A., and Kukwa, A. (2010) Molecular oncology focus-is carcinogenesis a 'mitochondriopathy'? J. Biomed. Sci. 17, 31
8. Shapovalov, Y., Hoffman, D., Zuch, D., de Mesy Bentley, K., and Eliseev, R. A. (2011) Mitochondrial dysfunction in cancer cells due to aberrant mitochondrial replication. J. Biol. Chem. 286, 22331-22338
9. Cairns, R. A., Harris, I. S., and Mak, T. W. (2011) Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95
10. Pedersen, P. L. (2007) Warburg, me and hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J. Bioenerg. Biomembr. 39, 211-222
11. Vousden, K. H., and Lane, D. P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283
12. Vousden, K. H., and Ryan, K. M. (2009) p53 and metabolism. Nat. Rev. Cancer 9, 691-700
13. Vaseva, A. V., and Moll, U. M. (2009) The mitochondrial p53 pathway. Biochim. Biophys. Acta 1787, 414-420
14. Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., and Hwang, P. M. (2006) p53 regulates mitochondrial respiration. Science 312, 1650-1653
15. Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N., Nakano, K., Bartrons, R., Gottlieb, E., and Vousden, K. H. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107-120
16. Rostovtseva, T. K., and Bezrukov, S. M. (2012)VDACinhibition by tubulin and its physiological implications. Biochim. Biophys. Acta 1818, 1526-1535
17. Maldonado, E. N., Sheldon, K. L., DeHart, D. N., Patnaik, J., Manevich, Y., Townsend, D. M., Bezrukov, S. M., Rostovtseva, T. K., and Lemasters, J. J. (2013) Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells. Regulation by free tubulin and erastin. J. Biol. Chem. 288, 11920-11929
18. Rasola, A., Sciacovelli, M., Pantic, B., and Bernardi, P. (2010) Signal transduction to the permeability transition pore. FEBS Lett. 584, 1989-1996
19. Hunter, D. R., and Haworth, R. A. (1979) The Ca2+-induced membrane transition in mitochondria &z.ast;1, &z.ast;2I. The protective mechanisms. Arch. Biochem. Biophys. 195, 453-459
20. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., and Dorn, G. W. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662
21. Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A., and Bernardi, P. (2005) Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J. Biol. Chem. 280, 18558-18561
22. Zamzami, N., Larochette, N., and Kroemer, G. (2005) Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ. 12, 1478-1480
23. Lafleur, E. A., Koshkina, N. V., Stewart, J., Jia, S.-F., Worth, L. L., Duan, X., and Kleinerman, E. S. (2004) Increased Fas expression reduces the metastatic potential of human osteosarcoma cells. Clin. Cancer Res. 10, 8114-8119
24. Macho, A., Decaudin, D., Castedo, M., Hirsch, T., Susin, S. A., Zamzami, N., and Kroemer, G. (1996) Chloromethyl X rosamine is an aldehyde fixable potential sensitive fluorochrome for the detection of early apoptosis. Cytometry 25, 333-340
25. Shapovalov, Y., Benavidez, D., Zuch, D., and Eliseev, R. A. (2010) Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma. Int. J. Cancer 127, 67-76
26. Métivier, D., Dallaporta, B., Zamzami, N., Larochette, N., Susin, S. A., Marzo, I., and Kroemer, G. (1998) Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes. Immunol. Lett. 61, 157-163
27. Petronilli, V., Miotto, G., Canton, M., Brini, M., Colonna, R., Bernardi, P., and Di Lisa, F. (1999) Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76, 725-734
28. Eliseev, R. A., Zuscik, M. J., Schwarz, E. M., O'Keefe, R. J., Drissi, H., and Rosier, R. N. (2005) Increased radiation-induced apoptosis of Saos2 cells via inhibition of NF-B: a role for c-Jun N-terminal kinase. J. Cell Biochem. 96, 1262-1273
29. Jia, S.-F., Worth, L. L., and Kleinerman, E. S. (1999) A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin. Exp. Metastasis 17, 501-506
30. Luu, H. H., Kang, Q., Park, J. K., Si, W., Luo, Q., Jiang, W., Yin, H., Montag, A. G., Simon, M. A., Peabody, T. D., Haydon, R. C., Rinker-Schaeffer, C. W., and He, T. C. (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin. Exp. Metastasis 22, 319-329
31. Petit, P. X., Goubern, M., Diolez, P., Susin, S. A., Zamzami, N., and Kroemer, G. (1998) Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition. FEBS Lett. 426, 111-116
32. Gregory, M. A., Bobardt, M., Obeid, S., Chatterji, U., Coates, N. J., Foster, T., Gallay, P., Leyssen, P., Moss, S. J., and Neyts, J. (2011) Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family. Antimicrob. Agents Chemother. 55, 1975-1981
33. Arismendi-Morillo, G. (2009) Electron microscopy morphology of the mitochondrial network in human cancer. Int. J. Biochem. Cell Biol. 41, 2062-2068
34. Gasparre, G., Romeo, G., Rugolo, M., and Porcelli, A. M. (2011) Learning from oncocytic tumors: why choose inefficient mitochondria? Biochim. Biophys. Acta 1807, 633-642
35. Rasola, A., and Bernardi, P. (2011) Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis. Cell Calcium 50, 222-233
36. Adams, J. M., and Cory, S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324-1337
37. Deveraux, Q. L., and Reed, J. C. (1999) IAP family proteins-suppressors of apoptosis. Genes Dev. 13, 239-252
38. Eliseev, R. A., Malecki, J., Lester, T., Zhang, Y., Humphrey, J., and Gunter, T. E. (2009) Cyclophilin D interacts with Bcl-2 and exerts an anti-apoptotic effect. J. Biol. Chem. 284, 9692-9699
39. Schubert, A., and Grimm, S. (2004) Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor. Cancer Res. 64, 85-93
40. Machida, K., Ohta, Y., and Osada, H. (2006) Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells. J. Biol. Chem. 281, 14314-14320
41. Nieminen, A. L., Byrne, A. M., Herman, B., and Lemasters, J. J. (1997) Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am. J. Physiol. Cell Physiol. 272, C1286-C1294
42. Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732
43. Lesnefsky, E. J., and Hoppel, C. L. (2003) Ischemia-reperfusion injury in the aged heart: role of mitochondria. Arch. Biochem. Biophys. 420, 287-297
44. Halestrap, A. P. (2006) Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem. Soc. Trans. 34, 232-237
45. Kimura, H., Braun, R. D., Ong, E. T., Hsu, R., Secomb, T. W., Papahadjopoulos, D., Hong, K., and Dewhirst, M. W. (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 56, 5522-5528
46. Yasui, H., Matsumoto, S., Devasahayam, N., Munasinghe, J. P., Choudhuri, R., Saito, K., Subramanian, S., Mitchell, J. B., and Krishna, M. C. (2010) Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. Cancer Res. 70, 6427-6436
47. Dewhirst, M. W., Cao, Y., and Moeller, B. (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 8, 425-437
48. Matsumoto, S., Yasui, H., Mitchell, J. B., and Krishna, M. C. (2010) Imaging cycling tumor hypoxia. Cancer Res. 70, 10019-10023